エルウィニアL-アスパラギナーゼ薬の世界市場動向・分析2018-2025

【英語タイトル】Global Erwinia L-Asparaginase Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D03559)・商品コード:QYR8D03559
・発行会社(調査会社):QYResearch
・発行日:2018年11月13日(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、エルウィニアL-アスパラギナーゼ薬の世界市場について調査・分析し、種類別には、大腸菌、ジャガイモ黒あし病、ペグ化に、用途別には、急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他に区分してまとめました。調査対象企業は、Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech等です。

・レポートの概要
・グローバル成長トレンド
・エルウィニアL-アスパラギナーゼ薬の世界市場規模
・エルウィニアL-アスパラギナーゼ薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別エルウィニアL-アスパラギナーゼ薬の価格動向
・エルウィニアL-アスパラギナーゼ薬の種類別市場規模(大腸菌、ジャガイモ黒あし病、ペグ化)
・エルウィニアL-アスパラギナーゼ薬の用途別市場規模(急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他)
・エルウィニアL-アスパラギナーゼ薬の北米市場(アメリカ、カナダ、メキシコ)
・エルウィニアL-アスパラギナーゼ薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・エルウィニアL-アスパラギナーゼ薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・エルウィニアL-アスパラギナーゼ薬の中南米市場(ブラジル等)
・エルウィニアL-アスパラギナーゼ薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・エルウィニアL-アスパラギナーゼ薬の市場規模予測
・エルウィニアL-アスパラギナーゼ薬の種類別市場予測2018-2025(大腸菌、ジャガイモ黒あし病、ペグ化)
・エルウィニアL-アスパラギナーゼ薬の用途別市場予測2018-2025(急性 リンパ芽球性 白血病、急性 骨髄性 白血病、その他)
・エルウィニアL-アスパラギナーゼ薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・エルウィニアL-アスパラギナーゼ薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・エルウィニアL-アスパラギナーゼ薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・エルウィニアL-アスパラギナーゼ薬の中南米市場予測2018-2025(ブラジル等)
・エルウィニアL-アスパラギナーゼ薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.In 2018, the global Erwinia L-Asparaginase Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Erwinia L-Asparaginase Drugs.

This study researches the market size of Erwinia L-Asparaginase Drugs, presents the global Erwinia L-Asparaginase Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Erwinia L-Asparaginase Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Erwinia L-Asparaginase Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech

Market Segment by Product Type
Escherichia coli
Erwinia Chrysanthemi
Pegylated

Market Segment by Application
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Erwinia L-Asparaginase Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Erwinia L-Asparaginase Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Erwinia L-Asparaginase Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Erwinia L-Asparaginase Drugs Market Size Growth Rate by Type
1.3.2 Escherichia coli
1.3.3 Erwinia Chrysanthemi
1.3.4 Pegylated
1.4 Market Segment by Application
1.4.1 Global Erwinia L-Asparaginase Drugs Market Share by Application (2018-2025)
1.4.2 Acute Lymphoblastic Leukemia
1.4.3 Acute Myeloid Leukemia
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Erwinia L-Asparaginase Drugs Market Size
2.1.1 Global Erwinia L-Asparaginase Drugs Revenue 2013-2025
2.1.2 Global Erwinia L-Asparaginase Drugs Sales 2013-2025
2.2 Erwinia L-Asparaginase Drugs Growth Rate by Regions
2.2.1 Global Erwinia L-Asparaginase Drugs Sales by Regions 2013-2018
2.2.2 Global Erwinia L-Asparaginase Drugs Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Erwinia L-Asparaginase Drugs Sales by Manufacturers
3.1.1 Erwinia L-Asparaginase Drugs Sales by Manufacturers 2013-2018
3.1.2 Erwinia L-Asparaginase Drugs Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Erwinia L-Asparaginase Drugs Revenue by Manufacturers (2013-2018)
3.2.2 Erwinia L-Asparaginase Drugs Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Erwinia L-Asparaginase Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Erwinia L-Asparaginase Drugs Price by Manufacturers
3.4 Key Manufacturers Erwinia L-Asparaginase Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Erwinia L-Asparaginase Drugs Market
3.6 Key Manufacturers Erwinia L-Asparaginase Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Escherichia coli Sales and Revenue (2013-2018)
4.1.2 Erwinia Chrysanthemi Sales and Revenue (2013-2018)
4.1.3 Pegylated Sales and Revenue (2013-2018)
4.2 Global Erwinia L-Asparaginase Drugs Sales Market Share by Type
4.3 Global Erwinia L-Asparaginase Drugs Revenue Market Share by Type
4.4 Erwinia L-Asparaginase Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Erwinia L-Asparaginase Drugs Sales by Application

6 North America
6.1 North America Erwinia L-Asparaginase Drugs Breakdown Data by Company
6.2 North America Erwinia L-Asparaginase Drugs Breakdown Data by Type
6.3 North America Erwinia L-Asparaginase Drugs Breakdown Data by Application
6.4 North America Erwinia L-Asparaginase Drugs Breakdown Data by Countries
6.4.1 North America Erwinia L-Asparaginase Drugs Sales by Countries
6.4.2 North America Erwinia L-Asparaginase Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Erwinia L-Asparaginase Drugs Breakdown Data by Company
7.2 Europe Erwinia L-Asparaginase Drugs Breakdown Data by Type
7.3 Europe Erwinia L-Asparaginase Drugs Breakdown Data by Application
7.4 Europe Erwinia L-Asparaginase Drugs Breakdown Data by Countries
7.4.1 Europe Erwinia L-Asparaginase Drugs Sales by Countries
7.4.2 Europe Erwinia L-Asparaginase Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Erwinia L-Asparaginase Drugs Breakdown Data by Company
8.2 Asia Pacific Erwinia L-Asparaginase Drugs Breakdown Data by Type
8.3 Asia Pacific Erwinia L-Asparaginase Drugs Breakdown Data by Application
8.4 Asia Pacific Erwinia L-Asparaginase Drugs Breakdown Data by Countries
8.4.1 Asia Pacific Erwinia L-Asparaginase Drugs Sales by Countries
8.4.2 Asia Pacific Erwinia L-Asparaginase Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Erwinia L-Asparaginase Drugs Breakdown Data by Company
9.2 Central & South America Erwinia L-Asparaginase Drugs Breakdown Data by Type
9.3 Central & South America Erwinia L-Asparaginase Drugs Breakdown Data by Application
9.4 Central & South America Erwinia L-Asparaginase Drugs Breakdown Data by Countries
9.4.1 Central & South America Erwinia L-Asparaginase Drugs Sales by Countries
9.4.2 Central & South America Erwinia L-Asparaginase Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Erwinia L-Asparaginase Drugs Breakdown Data by Type
10.2 Middle East and Africa Erwinia L-Asparaginase Drugs Breakdown Data by Application
10.3 Middle East and Africa Erwinia L-Asparaginase Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Erwinia L-Asparaginase Drugs Sales by Countries
10.3.2 Middle East and Africa Erwinia L-Asparaginase Drugs Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.1.4 Erwinia L-Asparaginase Drugs Product Introduction
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.2.4 Erwinia L-Asparaginase Drugs Product Introduction
11.2.5 Shire Recent Development
11.3 Medac GmbH
11.3.1 Medac GmbH Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.3.4 Erwinia L-Asparaginase Drugs Product Introduction
11.3.5 Medac GmbH Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.4.4 Erwinia L-Asparaginase Drugs Product Introduction
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Qianhong Bio-pharma
11.5.1 Qianhong Bio-pharma Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.5.4 Erwinia L-Asparaginase Drugs Product Introduction
11.5.5 Qianhong Bio-pharma Recent Development
11.6 Taj Pharmaceuticals
11.6.1 Taj Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.6.4 Erwinia L-Asparaginase Drugs Product Introduction
11.6.5 Taj Pharmaceuticals Recent Development
11.7 Mingxing Pharma
11.7.1 Mingxing Pharma Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.7.4 Erwinia L-Asparaginase Drugs Product Introduction
11.7.5 Mingxing Pharma Recent Development
11.8 SL Pharma
11.8.1 SL Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.8.4 Erwinia L-Asparaginase Drugs Product Introduction
11.8.5 SL Pharma Recent Development
11.9 United Biotech
11.9.1 United Biotech Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Erwinia L-Asparaginase Drugs
11.9.4 Erwinia L-Asparaginase Drugs Product Introduction
11.9.5 United Biotech Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Erwinia L-Asparaginase Drugs Sales Channels
12.2.2 Erwinia L-Asparaginase Drugs Distributors
12.3 Erwinia L-Asparaginase Drugs Customers

13 Market Forecast
13.1 Global Erwinia L-Asparaginase Drugs Sales and Revenue Forecast 2018-2025
13.2 Global Erwinia L-Asparaginase Drugs Sales Forecast by Type
13.3 Global Erwinia L-Asparaginase Drugs Sales Forecast by Application
13.4 Erwinia L-Asparaginase Drugs Forecast by Regions
13.4.1 Global Erwinia L-Asparaginase Drugs Sales Forecast by Regions 2018-2025
13.4.2 Global Erwinia L-Asparaginase Drugs Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Erwinia L-Asparaginase Drugs Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Erwinia L-Asparaginase Drugs Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Erwinia L-Asparaginase Drugs Product Picture
Table Erwinia L-Asparaginase Drugs Key Market Segments
Table Major Manufacturers Erwinia L-Asparaginase Drugs Covered in This Report
Table Global Erwinia L-Asparaginase Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Shar by Type 2013-2025
Figure Escherichia coli Figures
Table Major Manufacturers of Escherichia coli
Figure Erwinia Chrysanthemi Figures
Table Major Manufacturers of Erwinia Chrysanthemi
Figure Pegylated Figures
Table Major Manufacturers of Pegylated
Table Global Erwinia L-Asparaginase Drugs Market Share by Application 2018-2025 (K Units)
Figure Acute Lymphoblastic Leukemia Use Case
Figure Acute Myeloid Leukemia Use Case
Figure Other Use Case
Figure Erwinia L-Asparaginase Drugs Report Years Considered
Figure Global Erwinia L-Asparaginase Drugs Market Size 2013-2025 (Million US$)
Figure Global Erwinia L-Asparaginase Drugs Sales 2013-2018 (K Units)
Table Global Erwinia L-Asparaginase Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Erwinia L-Asparaginase Drugs Sales by Regions 2013-2018 (K Units)
Table Global Erwinia L-Asparaginase Drugs Sales Market Share by Regions 2013-2018
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share by Regions 2013-2018
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share by Regions in 2018
Table Global Erwinia L-Asparaginase Drugs Revenue by Regions 2013-2018 (Million US$)
Table Global Erwinia L-Asparaginase Drugs Revenue Market Share by Regions 2013-2018
Figure Global Erwinia L-Asparaginase Drugs Revenue Market Share by Regions 2013-2018
Figure Global Erwinia L-Asparaginase Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Erwinia L-Asparaginase Drugs Sales by Manufacturers (2013-2018) (K Units)
Table Global Erwinia L-Asparaginase Drugs Sales Share by Manufacturers (2013-2018)
Figure Global Erwinia L-Asparaginase Drugs Sales Share by Manufacturers in 2018
Table Erwinia L-Asparaginase Drugs Revenue by Manufacturers (2013-2018) (Million USD)
Table Erwinia L-Asparaginase Drugs Revenue Share by Manufacturers (2013-2018)
Figure Erwinia L-Asparaginase Drugs Value Share by Manufacturers in 2018
Table Global Erwinia L-Asparaginase Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Erwinia L-Asparaginase Drugs Price (2013-2018) (USD/Unit)
Table Key Manufacturers Erwinia L-Asparaginase Drugs Plants/Factories Distribution
Table Key Manufacturers Erwinia L-Asparaginase Drugs Area Served
Table Date of Key Manufacturers Enter into Erwinia L-Asparaginase Drugs Market
Table Key Manufacturers Erwinia L-Asparaginase Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Escherichia coli Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Erwinia Chrysanthemi Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Pegylated Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table Global Erwinia L-Asparaginase Drugs Sales Share by Type (2013-2018)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share by Type in 2017
Table Global Erwinia L-Asparaginase Drugs Revenue by Type (2013-2018) (Million US$)
Table Global Erwinia L-Asparaginase Drugs Revenue Share by Type (2013-2018)
Figure Global Erwinia L-Asparaginase Drugs Revenue Market Share by Type (2013-2018)
Figure Global Erwinia L-Asparaginase Drugs Revenue Market Share by Type in 2017
Table Erwinia L-Asparaginase Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table Global Erwinia L-Asparaginase Drugs Sales Share by Application (2013-2018)
Figure Global Sales Erwinia L-Asparaginase Drugs Market Share by Application (2013-2018)
Figure Global Sales Erwinia L-Asparaginase Drugs Market Share by Application in 2017
Figure North America Erwinia L-Asparaginase Drugs Sales Growth Rate 2013-2018 (K Units)
Figure North America Erwinia L-Asparaginase Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table North America Erwinia L-Asparaginase Drugs Sales by Company (2013-2018) (K Units)
Table North America Erwinia L-Asparaginase Drugs Sales Market Share by Company (2013-2018)
Figure North America Erwinia L-Asparaginase Drugs Sales Market Share by Company in 2018
Table North America Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table North America Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure North America Erwinia L-Asparaginase Drugs Market Share by Type in 2018
Table North America Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table North America Erwinia L-Asparaginase Drugs Sales Market Share by Application (2013-2018)
Figure North America Erwinia L-Asparaginase Drugs Market Share by Application in 2018
Table North America Erwinia L-Asparaginase Drugs Sales by Countries (2013-2018) (K Units)
Table North America Erwinia L-Asparaginase Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 North America Erwinia L-Asparaginase Drugs Sales Market Share by Countries
Table North America Erwinia L-Asparaginase Drugs Revenue by Countries (2013-2018) (Million US$)
Table North America Erwinia L-Asparaginase Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Erwinia L-Asparaginase Drugs Revenue Market Share by Countries
Figure United States Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Canada Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Europe Erwinia L-Asparaginase Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Europe Erwinia L-Asparaginase Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Erwinia L-Asparaginase Drugs Sales by Company (2013-2018) (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Market Share by Company (2013-2018)
Figure Europe Erwinia L-Asparaginase Drugs Sales Market Share by Company in 2018
Table Europe Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Europe Erwinia L-Asparaginase Drugs Market Share by Type
Table Europe Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Europe Erwinia L-Asparaginase Drugs Market Share by Application
Table Europe Erwinia L-Asparaginase Drugs Sales by Countries (2013-2018) (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Erwinia L-Asparaginase Drugs Sales Market Share by Countries
Table Europe Erwinia L-Asparaginase Drugs Revenue by Countries (2013-2018) (Million US$)
Table Europe Erwinia L-Asparaginase Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Erwinia L-Asparaginase Drugs Revenue Market Share by Countries in 2018
Figure Germany Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure France Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure UK Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Italy Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Russia Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Erwinia L-Asparaginase Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Erwinia L-Asparaginase Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales by Company (2013-2018) (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Company (2013-2018)
Figure Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Company in 2018
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure Asia Pacific Erwinia L-Asparaginase Drugs Market Share by Type in 2018
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Application (2013-2018)
Figure Asia Pacific Erwinia L-Asparaginase Drugs Market Share by Application in 2018
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share by Countries
Table Asia Pacific Erwinia L-Asparaginase Drugs Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Erwinia L-Asparaginase Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Erwinia L-Asparaginase Drugs Revenue Market Share by Countries
Figure China Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure China Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Japan Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Korea Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure India Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure India Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Australia Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Erwinia L-Asparaginase Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Erwinia L-Asparaginase Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Erwinia L-Asparaginase Drugs Sales by Company (2013-2018) (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Company (2013-2018)
Figure Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Company in 2018
Table Central & South America Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure Central & South America Erwinia L-Asparaginase Drugs Market Share by Type in 2018
Table Central & South America Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Application (2013-2018)
Figure Central & South America Erwinia L-Asparaginase Drugs Market Share by Application in 2018
Table Central & South America Erwinia L-Asparaginase Drugs Sales by Countries (2013-2018) (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Countries (2013-2018)
Figure Central & South America Erwinia L-Asparaginase Drugs Sales Market Share by Countries in 2018
Table Central & South America Erwinia L-Asparaginase Drugs Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Erwinia L-Asparaginase Drugs Revenue Market Share by Countries (2013-2018)
Figure Central & South America Erwinia L-Asparaginase Drugs Revenue Market Share by Countries in 2018
Figure Brazil Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Erwinia L-Asparaginase Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Erwinia L-Asparaginase Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Erwinia L-Asparaginase Drugs Market Share by Type
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Erwinia L-Asparaginase Drugs Market Share by Application
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Erwinia L-Asparaginase Drugs Sales Market Share by Countries
Table Middle East and Africa Erwinia L-Asparaginase Drugs Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Erwinia L-Asparaginase Drugs Revenue Market Share by Countries
Figure GCC Countries Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Erwinia L-Asparaginase Drugs Revenue Growth Rate (2013-2018) (K Units)
Table Jazz Pharmaceuticals Company Details
Table Jazz Pharmaceuticals Description and Business Overview
Table Jazz Pharmaceuticals Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Jazz Pharmaceuticals Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Jazz Pharmaceuticals Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Jazz Pharmaceuticals Recent Development
Table Shire Company Details
Table Shire Description and Business Overview
Table Shire Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Shire Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Shire Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Shire Recent Development
Table Medac GmbH Company Details
Table Medac GmbH Description and Business Overview
Table Medac GmbH Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Medac GmbH Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Medac GmbH Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Medac GmbH Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Description and Business Overview
Table Kyowa Hakko Kirin Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Kyowa Hakko Kirin Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Kyowa Hakko Kirin Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Kyowa Hakko Kirin Recent Development
Table Qianhong Bio-pharma Company Details
Table Qianhong Bio-pharma Description and Business Overview
Table Qianhong Bio-pharma Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Qianhong Bio-pharma Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Qianhong Bio-pharma Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Qianhong Bio-pharma Recent Development
Table Taj Pharmaceuticals Company Details
Table Taj Pharmaceuticals Description and Business Overview
Table Taj Pharmaceuticals Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Taj Pharmaceuticals Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Taj Pharmaceuticals Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Taj Pharmaceuticals Recent Development
Table Mingxing Pharma Company Details
Table Mingxing Pharma Description and Business Overview
Table Mingxing Pharma Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mingxing Pharma Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table Mingxing Pharma Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table Mingxing Pharma Recent Development
Table SL Pharma Company Details
Table SL Pharma Description and Business Overview
Table SL Pharma Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table SL Pharma Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table SL Pharma Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table SL Pharma Recent Development
Table United Biotech Company Details
Table United Biotech Description and Business Overview
Table United Biotech Erwinia L-Asparaginase Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table United Biotech Erwinia L-Asparaginase Drugs Sales Growth Rate (2013-2018)
Table United Biotech Erwinia L-Asparaginase Drugs Sales Market Share in Global Market
Table United Biotech Recent Development
Figure Erwinia L-Asparaginase Drugs Value Chain
Table Erwinia L-Asparaginase Drugs Distributors List
Table Erwinia L-Asparaginase Drugs Customers List
Table Global Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Revenue Forecast 2018-2025 (Million US$)
Table Global Erwinia L-Asparaginase Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Type 2018-2025
Table Global Erwinia L-Asparaginase Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Application 2018-2025
Table Global Erwinia L-Asparaginase Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Regions 2018-2025
Table Global Erwinia L-Asparaginase Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Erwinia L-Asparaginase Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Regions 2018-2025
Table North America Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table North America Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Countries 2018-2025
Table North America Erwinia L-Asparaginase Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure United States Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Canada Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure MexicoErwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Countries 2018-2025
Table Europe Erwinia L-Asparaginase Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure France Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure UK Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Italy Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Russia Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Erwinia L-Asparaginase Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure China Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Japan Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Korea Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure India Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Australia Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Indonesia Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Thailand Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Malaysia Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Philippines Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Figure Vietnam Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Erwinia L-Asparaginase Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Erwinia L-Asparaginase Drugs Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Erwinia L-Asparaginase Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Erwinia L-Asparaginase Drugs Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Erwinia L-Asparaginase Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Erwinia L-Asparaginase Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Erwinia L-Asparaginase Drugs Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech

★調査レポート[エルウィニアL-アスパラギナーゼ薬の世界市場動向・分析2018-2025] (コード:QYR8D03559)販売に関する免責事項を必ずご確認ください。
★調査レポート[エルウィニアL-アスパラギナーゼ薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆